Back to all bills
HR 1796119th CongressIntroduced
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Introduced: Oct 29, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
Bill to reauthorize and increase funding for sickle cell disease research, surveillance, prevention, and treatment programs.
Key Points
- 1Increases funding from $4.455M to $8.205M annually for fiscal years 2025-2029
- 2Expands focus to include treatment of sickle cell disease complications
- 3Authorizes grants, contracts, and cooperative agreements
- 4Includes sense of Congress supporting further research
- 5Supports comprehensive approach to heritable blood disorders
Impact Areas
Sickle cell disease researchRare disease fundingHealth disparitiesBlood disorder treatmentPublic health surveillance
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025